Free Trial
OTCMKTS:TBUFF

Tribute Pharmaceuticals Canada (TBUFF) Stock Price, News & Analysis

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free TBUFF Stock Alerts
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
50,100 shs
Average Volume
71,826 shs
Market Capitalization
$105.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
TBUFF stock logo

About Tribute Pharmaceuticals Canada Stock (OTCMKTS:TBUFF)

Tribute Pharmaceuticals Canada Inc., formerly Stellar Pharmaceuticals Inc., is a Canadian pharmaceutical company with a primary focus on the acquisition, licensing, development and promotion of healthcare products in Canada. The Company targets several therapeutic areas in Canada but has a particular interest in products for the treatment of pain, urology, dermatology and endocrinology/cardiology. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. On December 1, 2011, it acquired 100% of Tribute Pharmaceuticals Canada Ltd. and Tribute Pharma Canada Inc. As of December 31, 2011, its portfolio of assets includes nine products: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, and MycoVa. It has licensed BladderChek for the Canadian market from Inverness Medical Innovations North America, Inc. It eveloped Uracyst, a sterile 2 % sodium chondroitin sulfate solution available in a 20 milliliter vial.

TBUFF Stock News Headlines

May 2, 2023 | yahoo.com
When her brother died, she wrote a moving tribute on a frisbee. Now, his memory is being shared from one city to the next.
April 27, 2023 | finance.yahoo.com
MITSUBISHI TANABE PHARMA CANADA RECEIVES ENGAGEMENT LETTER FROM PAN-CANADIAN PHARMACEUTICAL ALLIANCE FOR RADICAVA® ORAL SUSPENSION
April 28, 2024 | InvestorPlace (Ad)
Has Jeff Bezos Found the Next Nvidia?
If you’ve sat back and watched companies like Nvidia and AMD soar over 2,000% over the past several years… And wondered what was next… This is a fast-moving story, but if you want the chance to profit alongside Jeff Bezos in the next big tech trend, go ahead and…
March 21, 2023 | mirror.co.uk
Kate Middleton pays tribute to 'incredibly sad' William as they mark St Patrick's Day
October 16, 2022 | bbc.co.uk
Queen Elizabeth II: Boats, tugs and ferries take part in Mersey tribute
October 4, 2022 | mirror.co.uk
Liz Truss pays tribute to Queen in 'passing of second Elizabethan age - speech in full
October 3, 2022 | bbc.co.uk
Friends and colleagues pay tribute to Bill Turnbull
September 18, 2022 | investing.com
Tribute Pharmaceuticals Canada Inc (TRX)
See More Headlines
Receive TBUFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tribute Pharmaceuticals Canada and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/31/2014
Today
4/28/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:TBUFF
CUSIP
N/A
CIK
N/A
Web
www.tributepharma.ca
Phone
+1-905-8761118
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
113,720,000
Free Float
N/A
Market Cap
$105.76 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover
The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Arnold Tenney (Age 70)
    Chairman of the Board
  • Robert Harris (Age 57)
    President, Chief Executive Officer, Director
  • Scott Langille (Age 56)
    Chief Financial Officer, Director
  • Janice M. Clarke (Age 52)
    Vice President - Finance and Administration
  • Steven H. Goldman (Age 57)
    Independent Director
  • John M. Gregory (Age 60)
    Independent Director
  • John J. Kime (Age 70)
    Independent Director
  • Francis Martin Thrasher (Age 61)
    Independent Director

TBUFF Stock Analysis - Frequently Asked Questions

How were Tribute Pharmaceuticals Canada's earnings last quarter?

Tribute Pharmaceuticals Canada Inc. (OTCMKTS:TBUFF) posted its quarterly earnings results on Monday, March, 31st. The company reported ($0.01) EPS for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. The company earned $2.90 million during the quarter.

How do I buy shares of Tribute Pharmaceuticals Canada?

Shares of TBUFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TBUFF) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
His win rate puts Warren Buffett to shame…
Investing Daily
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace